Emerging role of human basophil biology in health and disease

Current Allergy and Asthma Reports

Volumn 14, Issue 1, 2014, Pages

  Cromheecke, Jessica L ^a,b   Nguyen, Kathleen T ^a,b   Huston, David P ^a,b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Allergy; Anaphylaxis; Autoimmunity; Basophil; Infection; Malignancy

Indexed keywords

CYTOKINE;

ADAPTIVE IMMUNITY; ANAPHYLAXIS; ANIMAL; AUTOIMMUNE DISEASE; BASOPHIL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; INFECTION; LEUKOCYTE; NEOPLASM; REVIEW;

ADAPTIVE IMMUNITY; ANAPHYLAXIS; ANIMALS; AUTOIMMUNE DISEASES; BASOPHILS; CYTOKINES; HUMANS; HYPERSENSITIVITY; INFECTION; LEUKOCYTES; NEOPLASMS;

EID: 84894365818     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0408-2     Document Type: Article

References (102)

1. Chirumbolo S. State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve? Blood Transfus. 2012;10:148-64.
2. Durrani SR, Montville DJ, Pratt AS, et al. Innate immune responses to rhinovirus are reduced by the high-affinity IgE receptor in allergic asthmatic children. J Allergy Clin Immunol. 2012;130(2):489-95.
3. Siracusa MC, Artis D. Basophil functions during type 2 inflammation: initiators, regulators and effectors. Open Allergy J. 2010;3:46-51.
4. Wang H, Fang Y, Barrenas F, et al. Allergen challenge of peripheral blood mononuclear cells from patients with seasonal allergic rhinitis increases IL-17RB, which regulates basophil apoptosis and degranulation Clinical & Experimental Allergy. Clin Et Exp Allergy. 2010;40:1194-202.
5. Leung DYM, Boguniewicz M, Howell MD, et al. New insights into atopic dermatitis. J Clin Invest. 2004;113:651-7.
6. Dvorak HF, Hammond ME, Colvin RB, et al. Systemic expression of cutaneous basophil hypersensitivity. J Immunol. 1977;118:1549-57.
7. Dvorak AM, Mihm MC, Dvorak HF. Degranulation of basophilic leukocytes in allergic contact dermatitis reactions in man. J Immunol. 1976;116:687-95.
8. Dvorak HF, Mihm MC. Basophilic leukocytes in allergic contact dermatitis. J Exp Med. 1972;135:235-54.
9. Sabato V, Verweij MM, Bridts CH, et al. CD300a is expressed on human basophils and seems to inhibit IgE/FcεRI-dependent anaphylactic degranulation. Clin Cytom. 2012;82B:132-8.
10. Sokol CL, Medzhitov R. Emerging functions of basophils in protective and allergic immune responses. Mucosal Immunol. 2010;3(2):129-37. This review explained the role of basophils in promoting Th2 immune responses.
11. Siracusa MC, Saenz SA, Hill DA, et al. TSLP promotes IL-3-independent basophils hematopoiesis and type 2 inflammation. Nature. 2012;477:229-33.
12. Saenz SA, Noti M, Artis D. Innate immune cell populations function as initiators and effectors in Th2 cytokine responses. Trends Immunol. 2010;31(11):407-13.
13. Gibbs BF, Haas H, Falcone FH, et al. Purified human peripheral blood release interleukin-13 and preformed interleukin-4 following immunological activation. Eur J Immunol. 1996;26:2493-8.
14. MacGlashan Jr DW, White JM, Huang SK, et al. Secretion of interleukin-4 from basophils; the relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol. 1994;152:3006-16.
15. Min B, Prout M, Hu-Li J, et al. Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med. 2004;200:507-17.
16. Schroeder JT, MacGlashan Jr DW, Lichtenstein LM. Human basophils: mediator release and cytokine production. Adv Immunol. 2001;77:93-122.
17. Kim S, Shen T, Min B. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes. J Immunol. 2009;183:3033-9.
18. Perrigoue JG, Saenz SA, Siracusa MC, et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol. 2009;10:697-705.
19. Yoshimoto T, Yasuda K, Tanaka H, et al. Basophils contribute to Th2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol. 2009;10:706-12.
20. Sokol CL, Chu NQ, Yu S, et al. Basophils function as antigen-presenting cells an allergen-induced T helper type 2 response. Nat Immunol. 2009;10:713-20.
21. Khodoun MV, Orekhova T, Potter C, et al. Basophils initiate IL-4 production during a memory T-dependent response. J Exp Med. 2004;200:857-70.
22. Kim S, Prout M, Ramshaw H, et al. Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3. J Immunol. 2010;184:1143-7.
23. Galli SJ, Franco CB. Basophils are back! Immunity. 2008;28:495-7.
24. Voehringer D, Shinkai K, Locksley RM. Type 2 immunity reflects orchestrated recruitment of cells committed to IL-4 production. Immunity. 2004;20:267-77.
25. Min B. Basophils: what they 'can do' versus what they 'actually do'. Nat Immunol. 2008;9:1333-9.
26. Min B. Basophils induce Th2 immunity: is this final answer? Virulence. 2010;1:399-401.
27. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol. 2007;9:310-8.
28. Chen K, Xu W, Wilson M, et al. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol. 2009;10:889-98.
29. Charles N, Hardwick D, Daugas E, et al. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med. 2010;16(6):701-7. This was the first report potentially linking basophils to the pathogenesis of autoimmune lupus nephritis.
30. Warde N. Activated basophils exacerbate lupus nephritis by amplifying production of autoreactive IgE. Nat Rev Rheumatol. 2010;6(8):438.
31. Schuerwegh JM, Ioan-Facsinay A, Dorjee AL, et al. Evidence for a functional role of IgE anticitrullinated protein antibodies in rheumatoid arthritis. PNAS. 2010;107:2586-91. This article provides the first evidence for the potential role of basophils in rheumatoid arthritis.
32. Anyan WK, Kumagi T, Shimogawara RF, et al. Schistosome eggs have a direct role in the induction of basophils capable of a high level of IL-4 production: comparative study of single- and bisexual infection of Schistosoma mansoni in vivo. Trop Med Health. 2010;38(1):13-22.
33. Pelleau S, Diop S, Dia Badiane M, et al. Enhanced basophil reactivities during severe malaria and their relationship with the plasmodial histamine releasing factor PfTCTP. Infect Immune. 2012;80(8):2963-70.
34. Cerny-Reiterer S, Ghanim V, Hoermann G, et al. Identification of basophils as a major source of hepatocyte growth factor in chronic myeloid leukemia: a novel mechanism of BCR-ABL1 - independent disease progression. Neoplasia. 2012;14(7):572-84.
35. Yasuda H, Aritaka N, Ando J, et al. Chronic myelogenous leukemia with mild basophilia as the predominant manifestation at presentation. Intern Med. 2011;50:501-2.
36. Bain BJ, Heller M. Dysplastic basophils in the accelerated phase of chronic myelogenous leukemia. Am J Hematol. 2011;86:949.
37. Stacchini A, Demurtas A, Godio L. Flow cytometric detection of degranulated basophils in chronic myeloid leukemia in accelerated phase. Clin Cytom. 2011;80B:122-4.
38. Wimazal F, Germing U, Kundi M, et al. Evaluation of the prognostic significance of eosinophilia and basophilia in a larger cohort of patients with myelodysplastic syndromes. Cancer. 2010;116:2372-81.
39. Rudman SM, Josephs DH, Cambrook H, et al. Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcεRI-mediated basophil activation by a tumour- specific IgE antibody to evaluate the risk of type I hypersensitivity. Clin Exp Allergy. 2011;41:1400-13.
40. A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000 -Available from: http://www. clinicaltrials.gov/ct2/show/NCT01632852?term=CD123&rank=1 NLM Identifer: NCT01632852. This proposed clinical trial is the first to target CD123, and may establish a future therapy for myeloid leukemia treatment.
41. Meno KH. Allergen structures and epitopes. Allergy. 2011;66:19-21.
42. Saini SS, MacGlashan Jr DW. Assessing basophil functional measures during monoclonal anti-IgE therapy. J Immunol Methods. 2012;383:60-4.
43. Hida S, Tadachi M, Saito T, et al. Negative control of basophil expansion by IRF-2 critical for the regulation of Th1 / Th2 balance. Blood. 2005;106(6):2011-7.
44. Wakahara K, Baba N, Van VQ, et al. Human basophils interact with memory T cells to augment Th17 responses. Blood. 2012;120:4761-71.
45. Wada T, Ishiwata K, Koseki H, et al. Selective ablation of basophils in mice reveals their nonredundant role in acquired immunity against ticks. J Clin Invest. 2010;120:2867-75.
46. Valent P, Schmidt G, Mayer P, et al. Interleukin-3 is a differentiation factor for human basophils. Blood. 1989;73(7):1763-9.
47. Conti P, Kempuraj D, Di Gioaccino M, et al. Interleukin-6 and mast cells. Allergy Asthma Proc. 2002;23(5):331-5.
48. Schneider E, Thieblemont N, De Moraes ML, Dy M. Basophils: new players in the cytokine network. Eur Cytokine Netw. 2010;21(3):142-53.
49. Siracusa MC, Tait Wojno ED, Artis D. Functional heterogeneity in the basophil cell lineage. Adv Immunol. 2012;115:141-59. This article provides insight into potential heterogeneity in basophil development.
50. Stone KD, Prussin C, Metcalfe DD. IgE, mast cells, basophils, and eosinophils. J Allergy Clin Immunol. 2010;125(2):S73-80.
51. Charles N, Dema B, Rivera J. Reply to: basophils from humans with systemic lupus erythematosus do not express MHC-II. Nat Med. 2012;18:489-90.
52. Ford LS, Bloom KA, Nowak-Wegrzyn AH, et al. Basophil reactivity, wheal size, and immunoglobulin levels distinguish degrees of cow's milk tolerance. J Allergy Clin Immunol. 2013;131:180-6.
53. MacGlashan Jr D. Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes. Clin Exp Allergy. 2010;40:1365-77.
54. Crivellato E, Beatrice N, Ribatti D. The history of the controversial relationship between mast cells and basophils. Immunol Lett. 2011;141(1):10-7.
55. Kleine-Tebbe J, Erdmann S, Knol EF, et al. Diagnostic tests based on human basophils: potentials, pitfalls and perspectives. Int Arch Allergy Immunol. 2006;141:79-90.
56. Bieneman AP, Chichester KL, Chen YH, Schroeder JT. Toll-like receptor 2 ligands activate human basophils for both IgE-dependent and IgE-independent secretion. J Allergy Clin Immunol. 2005;115:295-301.
57. Yamada T, Sun Q, Zeibecoglou K, et al. IL-3, IL-5, granulocyte-macrophage colony-stimulating factor receptor alpha-subunit, and common beta-subunit expression by peripheral leukocytes and blood dendritic cells. J Allergy Clin Immunol. 1998;101:677-82.
58. Uguccioni M, Mackay C, Ochensberger B, et al. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. J Clin Invest. 1997;100:1137-43.
59. Siraganian RP, Hook WA. Mechanism of histamine release by formyl methionine-containing peptides. J Immunol. 1977;119:2078-83.
60. Tedeschi A, Salmaso C, Di Donato M, et al. Granulocyte-macrophage colony-stimulating factor and interleukin-3 cause basophil histamine release by a common pathway: downregulation by sodium. Immunology. 1999;96:164-70.
61. Bischoff SC, Brunner T, De Weck AL, Dahinden C. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med. 1990;172:1577-82.
62. Jürgensen H, Braam U, Kownatzki E, et al. Human C5a induces a substantial histamine release in human basophils but not in tissue mast cells. Int Arch Allergy Appl Immunol. 1988;85(4):487-8.
63. Komiya A, Nagase H, Okugawa S, et al. Expression and function of toll-like receptors in human basophils. Allergy Immunol. 2006;140 suppl 1:23-7.
64. Smithgall MD, Comeau MR, Yoon B, et al. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells. Int Immunol. 2008;20(8):1019-30.
65. Watanabe T, Yamashita K, Sakurai T, et al. Toll-like receptor activation in basophils contributes to the development of IgG4-related disease. J Gastroenterol. 2012;48(2):247-53.
66. Mochizuki A, Mceuen AR, Buckley MG, et al. The release of basogranulin in response to IgE-dependent and IgE-independent stimuli: validity of basogranulin measurement as an indicator of basophil activation. J Allergy Clin Immunol. 1995;12(1):102-8.
67. Lantz CS, Min B, Tsai M, et al. IL-3 is required for increases in blood basophils in nematode infection in mice and can enhance IgE-dependent IL-4 production by basophils in vitro. Lab Investig. 2008;88:1134-42.
68. Takao K, Tanimoto Y, Fujii M, et al. In vitro expansion of human basophils by interleukin-3 from granulocyte colony-stimulating factor-mobilized peripheral blood stem cells. Clin Exp Allergy. 2003;33:1561-7.
69. Iikura M, Yamaguchi M, Fujisawa T, et al. Secretory IgA induces degranulation of IL-3-primed basophils. J Immunol. 1998;161:1510-5.
70. Verweij MM, Sabato V, Nullens S, et al. STAT5 in human basophils: IL-3 is required for its FcεRI-mediated phosphorylation. Clin Cytom. 2012;82B:101-6.
71. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, et al. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood. 2009;113:1526-34.
72. Cady CT, Powell MS, Harbeck RJ, et al. IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcγRIIA and FcγRIIB. Immunol Lett. 2010;130:57-65.
73. Patella V, Florio G, Petraroli, Marone G. HIV-1 gp120 induces IL-4 and IL-13 release from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. J Immunol. 2000;164:589-95.
74. Chen K, Cerutti A. The function and regulation of immunoglobulin D. Curr Opin Immunol. 2011;23(3):345-52.
75. Kroeger KM, Sullivan BM, Locksley RM. IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway. J Leuko Biol. 2009;86:769-78.
76. Seok J, Shaw Warren H, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. PNAS. 2013;110:3507-12. Evidence was presented that the current mouse model for inflammatory diseases may not be appropriate for translation to understanding human disease.
77. Suzukawa M, Hirai K, Iikura M, et al. IgE- and FcεRI-mediated migration of human basophils. Int Immunol. 2005;17:1249-55.
78. Bochner BS, McKelvey AA, Sterbinsky SA, et al. IL-3 augments adhesiveness for endothelium and CD11b expression in human basophils but not neutrophils. J Immunol. 1990;145(6):1832-7.
79. Iikura M, Ebisawa M, Yamaguchi M, et al. Transendothelial migration of human basophils. J Immunol. 2004;173:5189-95.
80. Lie WJ, Homburg E, Kuijers TW, et al. Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils. Clin Exp Allergy. 2003;33:1125-34.
81. Tsujimura Y, Obata K, Mukai K, et al. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity. 2008;2:581-9.
82. Steiner M, Harrer A, Lang R, et al. Basophil activation test for investigation of IgE-mediated mechanisms in drug hypersensitivity. J Visualized Exp. 2011;55:1-6.
83. Chirumbolo S. Basophil activation test to optimize the diagnosis of adverse effects following immunization to vaccines. Iran J Asthma Immunol. 2013;12:196-202.
84. Macglashan Jr DW. Basophil activation testing. J Allergy Immunol. 2013;132(4):777-87. This review discusses the potential of BAT to assess functional changes in basophils.
85. De Weck AL, Sanz ML, Gamboa PM, et al. Diagnostic tests based on human basophils: more potentials and perspectives than pitfalls. Int Allergy Immunol. 2008;146:177-89.
86. Khan FM, Ueno-Yamanouchi A, Serushago B, et al. Basophil activation test compared to skin prick test and fluorescence enzyme immunoassay for aeroallergen-specific Immunoglobulin-E. Allergy Clin Immunol. 2012;8:1-13.
87. Savage JH, Courneya JP, Sterba PM, et al. Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy. J Allergy Clin Immunol. 2012;130:1123-9. Provided here is the application of omalizumab and its effects in modulating immune response to allergy challenge.
88. Blank S. Components and mechanisms in diagnosis and therapy of hymenoptera venom allergy. University Dissertation - Hamburg. 2009;1-70.
89. Konstantinou GN, Asero R, Ferrer M, et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria. Allergy. 2013;68:27-36. Urticaria as an autoimmune disorder involving basophils is discussed.
90. Gentinetta T, Pecaric-Petkovic T, Wan D, et al. Individual IL-3 priming is crucial for consistent in vitro activation of donor basophils in patients with chronic urticaria. J Allergy Clin Immunol. 2011;128:1227-34.
91. Imoto Y, Tokunaga T, Matsumoto Y, et al. Cystatin SN upregulation in patients with seasonal allergic rhinitis. PLOS One. 2013;8(8):1-8.
92. Zeiger S, Heller S. Development of nasal basophilic cells and nasal eosinophils from age 4 months through 4 years in children of atopic parents. J Allergy Clin Immunol. 1993;91(3):723-34.
93. Kepley CL, McFeeley PJ, Oliver JM, Lipscomb MF. Immunohistochemical detection of human basophils in postmortem cases of fatal asthma. Am J Resp Crit Care Med. 2011;164:1053-8.
94. Siracusa MC, Kim BS, Spergel JM, Artis D. Basophils and allergic inflammation. J Allergy Clin Immunol. 2013;132:789-801. This review encapsulates many functions of basophils in allergy but is skewed to mouse biology.
95. Botturi K, Langelot M, Lair D, et al. Preventing asthma exacerbations: what are the targets? Pharmacol Ther. 2011;131(1):114-29.
96. Shelley WB, Resnik SS. Basophil degranulation induced by oral poison ivy antigen. Arch Dermatol. 1965;92:147-50.
97. Brandt EB, Sivaprasad U. Th2 cytokines and atopic dermatitis. J Clin Cell Immunol. 2011;2(3):1-25.
98. Sabroe I, Jones EC, Usher LR, et al. Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J Immunol. 2002;168:4701-10.
99. Wong S, McLaughlin J, Cheng D, et al. IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease. Proc Natl Acad Sci U S A. 2003;100(20):11630-5.
100. Noti M, Tait Wojno ED, Kim BS, et al. Thymic stromal lymphopoietin- elicited basophil responses promote eosinophilic esophagitis. Nat Med. 2013;19:1005-13.
101. Roan F, Bell BD, Stoklasek TA, et al. The multiple facets of thymic thromal lymphopoietin (TSLP) during allergic inflammation and beyond. J Leukoc Biol. 2012;91(6):1-10.
102. Bogiatzi SI, Guillot-Delost M, Cappuccio A, et al. Multiple-checkpoint inhibition of thymic stromal lymphopoietin - induced TH2 response by TH17-related cytokines. J Allergy Clin Immunol. 2012;1:233-40.